BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaler shows promise for lung decline in transplant kids
Disease control TerminatedThis study tested whether a combination inhaler (fluticasone and salmeterol) could improve lung function in children aged 6-17 who had a stem cell transplant and experienced a drop in lung capacity. The goal was to prevent a serious lung condition called bronchiolitis obliterans.…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 02:14 UTC
-
New inhaled therapy aims to save lungs after transplant
Disease control TerminatedThis study tested an inhaled form of cyclosporine A (L-CsA) plus standard care in 164 people who had a lung transplant and developed bronchiolitis obliterans, a condition that scars the small airways. The goal was to see if the drug could slow the decline in lung function over 24…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 26, 2026 02:06 UTC
-
Experimental drug studied for rare lung condition after transplant
Disease control TerminatedThis early-stage study tested the safety of a drug called itacitinib in 8 adults who developed bronchiolitis obliterans syndrome (a type of lung scarring) after receiving a donor stem cell transplant. The goal was to see if the drug could help control the lung disease without cau…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:53 UTC